| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Problem-Solving Success Tip: Communicate! Don't Leave Your Key Stakeholders Guessing |
|
Digg It - Problem-Solving Success Tip: Communicate! Don't Leave Your Key Stakeholders Guessing
We are generally not very good about keeping others informed about the progress we’re m According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product aking, especially if there isn’t much. You’re more likely to get support and understand ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng if you get the word out honestly about what is and isn’t happening. As you start you lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r problem-solving project, establish a communication plan and follow it. Specify who ne here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ds what information about your effort, when they need it and how you are going to provi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e it. Make the plan appropriate to your problem, the culture of your company and the in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc dividuals involved. Different participants in the project will need different informat easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi on. For example, the members of the problem-solving team need all the details about eve nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rything. Managers who want the problem solved but aren’t personally participating in th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ resolution generally need assurance that things are proceeding appropriately, or timel ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi notification if they aren’t. They don’t want to guess or wade through a ton of detail ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to try to figure out how things stand. For them, regular status reports are generally s dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod fficient. Nobody likes unpleasant surprises, so be sure to identify who needs to know w cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hat about the various bumps you’ll hit along road. Once you’ve developed your communic tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tions plan, tell everyone involved what it is—-then do what you promise. It seem t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel obvious, but this is a major failing in many projects. Make changes as necessary. If p ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eople know that they’re getting the information that they need when they need it, they y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products on’t waste your time with status-check phone calls or emails. Your meetings will be sho . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rter and easier to manage because you won’t have extra people coming just in case somet elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ing comes up that they should know. copyright 2005. Jeanne Sawyer. All Rights Reserved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:From Generic to Best Seller- 5 Steps to Changing Your Personal Brand Name Substitute Teaching - Who Are You Today? Nurturing Your Staff in the Corporate Environment
|